This approach has also seen relatively well-documented success in other NF1-associated tumors, including low-grade gliomas (LGGs) and plexiform neurofibromas [15,68], with formal clinical trial assessment underway [69,70,71]. The gene discussed is NF1; the disease is plexiform neurofibroma.